← Back to Patent Explorer
DE2507902A1 Expired / Lapsed DE ⏱️ 0.0 years remaining

(3-Isopropylamino-2-hydroxypropoxy) pyridines - cardioselective beta-receptor stimulants

Assignee: Novartis AG
•
Filing: 1975-02-24
•
Granted: —
•
Expires: 1995-02-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Pyridine derivs. of formula (I), their salts and optical antipodes are new: Py.O.CH2.CH(OH).CH2.NH.CH(CH3)3 (I) (where Py = 2- or 3-pyridyl). (I) are cardioselective beta-receptor stimulants i.e., they increase myocardial contraction strength and cardiac frequency. The 3-pyridyl isomer differs from known stimulants such as isoproterenol in that it causes a redn. in arterial blood pressure only at doses much greater than that required for increasing contraction strength etc. The 2-pyridyl isomer also has beta-receptor blocking activity so may be used in treatment af arrythmia and angina pectoris. (I) also inters. for other pharmaceuticals. The daily oral dose for a 75 kg. mammal is 40-150 mg. (I) may be used in human or veterinary medicine.

Inventors

  • 👤 Knut A Dr Jaeggi
  • 👤 Franz Dr Ostermayer
  • 👤 Herbert Dr Schroeter

Bibliographic Details

Application Number —
Jurisdiction DE
Data Source google_patents
Last Synchronized 2026-11-04 06:20
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/60; C07D213/62; C07D213/63; C07D213/64; C07D213/65

Claims Analysis

Total Claims: 0
No claims parsed yet. Click Sync Now above to re-index claims from Google Patents.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag